• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.

作者信息

Cano J P, Rigault J P, Aubert C, Carcassonne Y, Seitz J F

出版信息

Bull Cancer. 1979;66(1):67-74.

PMID:420949
Abstract

An analytic method, sensitive to 5 ng/ml and specific, has been set up for the determination of unchanged 5-fluorouracil in human plasma, using gas chromatography--mass spectrometry. Its applications to the pharmacokinetic study of unchanged 5-Fluorouracil in man following an intravenous bolus, 8 hours infusion and oral administration confirmed the non-linearity of the kinetic model. (The clearances obtained with an infusion--from 5 to 60 1/min--are 10 to 60 times higher than the ones observed with a bolus--from 0.5 to 1.4 1/min.) The bioavailability of the oral form seems to be about 60 per cent and the absorption appears to be very fast. A attempt to search a mathematical non-linear model of the 5-Fluorouracil kinetics, using computer simulation, is presented.

摘要

相似文献

1
Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
Bull Cancer. 1979;66(1):67-74.
2
Comparative determinations of 5-fluorouracil in plasma using GC/MS and HPLC.采用气相色谱/质谱联用仪(GC/MS)和高效液相色谱法(HPLC)对血浆中的5-氟尿嘧啶进行对比测定。
Arzneimittelforschung. 1981;31(12):2048-53.
3
Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.用于同时测定血浆中替加氟、5-氟尿嘧啶和5-氟二氢尿嘧啶的灵敏串联质谱-液相色谱测定法
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):153-60. doi: 10.1016/j.jchromb.2005.07.023.
4
Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.口服、快速静脉注射和缓慢输注5-氟尿嘧啶的药代动力学。
Cancer Res. 1980 Jul;40(7):2223-8.
5
Disposition of 5-fluorouracil after intravenous bolus doses of a commercial formulation to cancer patients.癌症患者静脉推注商用制剂后5-氟尿嘧啶的处置情况。
Cancer Res. 1977 Nov;37(11):3981-4.
6
Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.通过同位素稀释-质谱碎片分析法测定大鼠和人体中5-氟尿嘧啶(NSC-19893)的血浆水平。
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):279-86.
7
Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.癌症患者肝动脉输注和静脉输注5-氟尿嘧啶时的稳态非线性药代动力学
Cancer Res. 1986 Mar;46(3):1499-506.
8
Determination of ftorafur and 5-fluorouracil levels in plasma and urine.血浆和尿液中呋喃氟尿嘧啶及5-氟尿嘧啶水平的测定
Res Commun Chem Pathol Pharmacol. 1976 May;14(1):89-102.
9
Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.采用高效液相色谱-大气压化学电离质谱法灵敏测定大鼠血浆中20(S)-原人参二醇:在大鼠体内的药代动力学研究应用
J Pharm Biomed Anal. 2008 Dec 15;48(5):1476-80. doi: 10.1016/j.jpba.2008.09.045. Epub 2008 Oct 8.
10
Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.大鼠体内5-氟尿嘧啶和5'-脱氧-5-氟尿苷的药代动力学研究
J Pharmacol Exp Ther. 1983 Oct;227(1):174-80.

引用本文的文献

1
Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients.癌症患者静脉注射5-氟尿嘧啶后消除的非线性药代动力学。
Cancer Chemother Pharmacol. 1982;9(3):173-8. doi: 10.1007/BF00257748.
2
Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.
Cancer Chemother Pharmacol. 1981;6(1):19-23. doi: 10.1007/BF00253005.
3
Anticancer drug pharmacodynamics.抗癌药药效学
Cancer Chemother Pharmacol. 1985;14(3):177-83. doi: 10.1007/BF00258112.
4
Clinical pharmacology of 5-fluorouracil.5-氟尿嘧啶的临床药理学
Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002.
5
High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach.
Cancer Chemother Pharmacol. 1979;3(3):189-96. doi: 10.1007/BF00262421.